Informations sur les droits de vote et les actions au 30 avril 2024 Le 10 mai 2024 Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : Euronext ParisCompartiment : Compartiment ACode ISIN : FR0000054470Site web : Date Nombre total d’actions composant le capital social Nombre total de droits de vote Total brut (1) Total net (2) 30/04/2024 127 450 324 138 554 769 138 554 769 ...
Two Directors at UCB SA sold/bought 1,385 shares at 128.760USD. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
>Conference call feedback: 2024 guidance confirmed but no indication on medium-term prospects after the abandonment (unsurprisingly) of the 2025 targets - CompuGroup published yesterday morning a soft Q1 2024, slightly below expectations (first take link published yesterday). Below are the main elements from the conference call: 1/ 2024 guidance confirmed with a more favourable base effect in H2. As anticipated, the momentum in H1 has been penalised by the base effec...
>Feedback conf. call : guidance 2024 confirmée mais aucune indication sur les perspectives MT après l’abandon (sans surprise) des objectifs 2025 - CompuGroup a publié hier matin un T1 2024 soft et légèrement en deçà des attentes (lien first take publiée hier). Ci-dessous les principaux éléments que nous retenons de la conférence call : 1/ Guidance 2024 confirmée avec un effet de base plus favorable au S2. Comme anticipé, la dynamique du S1 est pénalisée par l’effet d...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
>Q1 2024 slightly below expectations - This morning, CompuGroup published its Q1 2024 results, which came in a slightly below expectations. Q1 revenues were down 2% y-o-y to € 285m (-1% vs css). Excluding the TI effect, organic growth was up 3%. By division, HIS continued to drive growth in Q1 with revenues up 7% y-o-y to € 78m (-2% vs the consensus) mainly thanks to the ramp-up of the Hospital Future Act programme in Germany. On the other hand, the performance by AIS...
>Q1 2024 slightly below expectations - This morning, CompuGroup published its Q1 2024 results, which came in a slightly below expectations. Q1 revenues were down 2% y-o-y to € 285m (-1% vs css). Excluding the TI effect, organic growth was up 3%. By division, HIS continued to drive growth in Q1 with revenues up 7% y-o-y to € 78m (-2% vs the consensus) mainly thanks to the ramp-up of the Hospital Future Act programme in Germany. On the other hand, the performance by AIS...
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Quarter Results/Quarterly / Interim Statement CompuGroup Medical with solid first quarter against strong prior year 08.05.2024 / 07:07 CET/CEST The issuer is solely responsible for the content of this announcement. CompuGroup Medical with solid first quarter against strong prior year Revenues down by 2%, organic growth of 3% adjusted for TI one-offs Recurring revenue share increases to 75% Advancing digitization in German and French healthcare Continuing revenue conversion of hospital order backlog Leverage r...
EQS-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung CompuGroup Medical mit solidem ersten Quartal gegenüber starkem Vorjahreszeitraum 08.05.2024 / 07:07 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CompuGroup Medical mit solidem ersten Quartal gegenüber starkem Vorjahreszeitraum Umsatzrückgang um 2 %, organisches Wachstum bereinigt um TI-Einmaleffekte bei 3 % Anteil der wiederkehrenden Umsätze steigt auf 75 % Fortschreitende Digitalisierung im deutschen und französischen Gesu...
KBC Group: Update regarding the KBC Group share buyback programme Within the framework of the share buyback programme announced on 10 August 2023 after trading hours, KBC Group NV wishes to advise that the following transactions took place on Euronext Brussels’ regulated market between 29 April 2024 and 3 May 2024, included: Date No. of shares Total price Average price Lowest price Highest price 29-04-2024 74 000 € 5 123 272 € 69.23 € 68.78 € 69.68 30-04-2024 73 000 € 5 091 903 € 69.75 € 69.28 € 69.90 02-05-2024 73 000 € 5 104 897 € 69.93 € 69.26 € 70.86 03-05-20...
KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe Dans le cadre du programme de rachat d'actions propres, annoncé le 10 août 2023 hors séance boursière, KBC Groupe SA souhaite communiquer que les transactions suivantes ont eu lieu sur le marché réglementé de Euronext Bruxelles entre 29 avril 2024 et 3 mai 2024 inclus: Date No. des actions Prix total Prix moyen Prix plus bas Prix plus haut 29-04-2024 74 000 € 5 123 272 € 69.23 € 68.78 € 69.68 30-04-2024 73 000 € 5 091 903 € 69.75 € 69.28 € 69.90 02-05-2024 73 000 € 5 104 897 € ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.